Broadly-neutralizing anti-HIV antibodies
The present invention relates to anti-HIV antibodies. Also disclosed are related methods and compositions. HIV causes acquired immunodeficiency syndrome (AIDS), a condition in humans characterized by clinical features including wasting syndromes, central nervous system degeneration and profound immu...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
14.08.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to anti-HIV antibodies. Also disclosed are related methods and compositions. HIV causes acquired immunodeficiency syndrome (AIDS), a condition in humans characterized by clinical features including wasting syndromes, central nervous system degeneration and profound immunosuppression that results in life-threatening opportunistic infections and malignancies. Since its discovery in 1981, HIV type 1 (HIV-1) has led to the death of at least 25 million people worldwide. |
---|---|
Bibliography: | Application Number: US201314436608 |